Torsten Malmström
Chief Tech/Sci/R&D Officer bij CAMURUS AB
Vermogen: 2 M $ op 31-03-2024
Profiel
Torsten Malmström is currently the Chief Technical Officer at Camurus AB.
Previously, he worked as the Director-Pharmaceutical Development at Zealand Pharma A, the Development Director at PolyPeptide Laboratories (Sweden) AB, and the Team Manager at AstraZeneca AB.
Dr. Malmström holds a doctorate degree from the University of Lund.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CAMURUS AB
0.08% | 31-12-2022 | 46 858 ( 0.08% ) | 2 M $ | 31-03-2024 |
Actieve functies van Torsten Malmström
| Bedrijven | Functie | Begin |
|---|---|---|
| CAMURUS AB | Chief Tech/Sci/R&D Officer | 01-01-2013 |
Eerdere bekende functies van Torsten Malmström
| Bedrijven | Functie | Einde |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
PolyPeptide Laboratories (Sweden) AB
 PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Corporate Officer/Principal | - |
Opleiding van Torsten Malmström
| University of Lund | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| CAMURUS AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Health Technology |
